Jasper Therapeutics, Inc. (JSPR) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$83.88M | -10.0% |
| 2024 | -$76.24M | -10.7% |
| 2023 | -$68.86M | -34.5% |
| 2022 | -$51.20M | -39.0% |
| 2021 | -$36.83M | -78.1% |
| 2020 | -$20.68M | -813.2% |
| 2019 | $2.90M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$83.88M | -10.0% |
| 2024 | -$76.24M | -10.7% |
| 2023 | -$68.86M | -34.5% |
| 2022 | -$51.20M | -39.0% |
| 2021 | -$36.83M | -78.1% |
| 2020 | -$20.68M | -813.2% |
| 2019 | $2.90M | — |